Because China is a country with a high incidence of cardiovascular and
cerebrovascular diseases, the number of deaths due to cardiovascular and
cerebrovascular diseases is higher than that of cancer every year. Especially in
recent years, patients with cerebral infarction have become younger and younger.
How can ordinary people use the economy? Affordable lifesavers? In the past 12
years, many large hospitals have experienced shortages of kinase injections. If
there is a large-scale shortage or out of stock, the consequences will be
One: The number of raw material processing (crude product processors) is
small and the output is low, which leads to the increase in the price of raw
materials, and the price of natural medical urokinase injection remains high
(and the imported urokinase injection is higher than the domestic urokinase
injection. many times). Solution: call on the whole society, to need more raw
material processors (rough product processors) to join in, so that the overall
cost can be reduced.
Two: The pattern is small and the horizon is narrow. Most investors only
focus on projects with high-speed growth and fast-moving consumption but do not
see this good project that benefits the country and the people, ecological
benefits, corporate economic benefits, and social benefits. Solution: We only
need the right people, the right ideas, and the right pattern, and it will no
longer be difficult to achieve profitability and economic benefits.
The above is the relevant content summarized by the editor of Kangyuan
Company. If you want to know more, please continue to follow us. We will
regularly update you about Human chorionic gonadotropin, Human Menopausal
Gonadotropin supplier, Urofollitropin price, Urokinase manufacturer, and Hormone
API Manufacturer Related content, I hope to help you.